Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2012
08/14/2012US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/14/2012US8241625 Medicament and a method for regulation of the vascular tone
08/14/2012CA2520628C T-type calcium channel blocker
08/14/2012CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/14/2012CA2446622C Isostearic acid salts as permeation enhancers
08/14/2012CA2404679C Adenine binding g-protein coupled receptors
08/14/2012CA2386069C Indolyl-3-glyoxylic acid derivatives as antitumor agents
08/09/2012WO2012106472A1 Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase
08/09/2012WO2012106393A2 Withanolide isolated from physalis longifolia and analogs and methods of use thereof
08/09/2012WO2012106313A2 Ubiquitin interacting motif peptides as cancer therapeutics
08/09/2012WO2012105707A1 Method of treating ischemia/reperfusion injury
08/09/2012WO2012105610A1 Medicinal agent for prevention or treatment of diseases associated with intraocular neovascularization and/or intraocular vascular hyperpermeability
08/09/2012WO2012105573A1 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND α-GLUCOSIDASE INHIBITOR COMPRISING SAME
08/09/2012WO2012104462A1 Heptapeptides and the use thereof for controlling hypertension
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012WO2012103807A1 Bifunctional anti-platelet aggregation medicament and uses thereof
08/09/2012WO2012103777A1 Compound isolated from monascus purpureus, preparation method therefor and uses thereof
08/09/2012WO2012075342A3 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
08/09/2012WO2011087981A3 Clinical benefits of eicosapentaenoic acid in humans
08/09/2012US20120204281 Drg11-responsive (dragon) gene family
08/09/2012US20120204280 Drg11-responsive (dragon) gene family
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120203162 Method for treating neovascularization
08/09/2012US20120203147 Vasodilator-enhanced cardiopulmonary resuscitation
08/09/2012US20120202876 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/09/2012US20120202862 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202856 Substituted benzimdazole derivatives useful as trpm8 receptor modulators
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202846 Molecular target of neurotoxicity
08/09/2012US20120202845 Diuretics
08/09/2012US20120202837 Spirocyclic piperidine derivatives useful as renin inhibitors
08/09/2012US20120202836 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
08/09/2012US20120202829 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders
08/09/2012US20120202824 Pyrazines as delta opioid receptor modulators
08/09/2012US20120202818 Ureidophenyl substituted triazine derivatives and their therapeutical applications
08/09/2012US20120202817 Compounds having 4-pyridylalkylthio group as a substituent
08/09/2012US20120202816 Novel compounds
08/09/2012US20120202812 Heteroaryls and uses thereof
08/09/2012US20120202810 Substituted 4-aminocyclohexane derivatives
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202807 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202802 Spirocyclic compounds as modulators of chemokine receptor activity
08/09/2012US20120202795 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
08/09/2012US20120202791 Tricyclic and Tetracyclic Systems with Activity on the Central Nervous and Vascular Systems
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202783 Fused heterocyclic compounds as orexin receptor modulators
08/09/2012US20120202774 Acyloxy- and phosphoryloxy-butadiene-fe(co)3 complexes as enzyme-triggered co-releasing molecules
08/09/2012US20120202769 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
08/09/2012US20120202764 Low molecular weight pharmacological activity modulators
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202762 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202757 Antihypertensive composition containing a ginsenoside-enriched fraction
08/09/2012US20120202756 Use of prodrugs to avoid gi mediated adverse events
08/09/2012US20120202733 Inhibition of trem receptor signaling with peptide variants
08/09/2012US20120202732 Modified aav capsid polypeptides
08/09/2012US20120201907 Nitroxyl Progenitors in the Treatment of Heart Failure
08/09/2012US20120201888 Pharmaceutical Compositions
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201856 Use of Mycobacterium Bovis BCG killed by Extended Freeze Drying (EFD) For Preventing or Treating Atherosclerosis
08/09/2012US20120201853 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201826 Anti-RANTES Antibodies and Methods of Use Thereof
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201816 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/09/2012US20120201809 Multifunctional antibody conjugates
08/09/2012US20120201800 Methods and Devices for Sustained In-Vivo Release Of an Active Agent
08/09/2012US20120201799 Devices, systems and methods for cell modification
08/09/2012US20120201791 Methods of treating diseases or conditions using mesenchymal stem cells
08/09/2012US20120201790 Promoters exhibiting endothelial cell specificity and methods of using same
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201754 Phosphodiesterase 1-targeting tracers and methods
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012CA2826178A1 A compound separated from monascus-fermented rice, the preparation method and uses thereof
08/09/2012CA2825884A1 Ubiquitin interacting motif peptides as cancer therapeutics
08/09/2012CA2823870A1 Inhibitors of the interaction of the sigma-1 receptor with herg for use in the treatment of cancer
08/09/2012CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors
08/08/2012EP2484697A1 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
08/08/2012EP2484675A1 Novel phenylpyridine derivative and medicinal agent comprising same
08/08/2012EP2484669A1 Novel phenol derivative
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484379A1 Agent for prevention of atherosclerosis
08/08/2012EP2484370A1 Composition having lipolysis-promoting effect
08/08/2012EP2484369A1 Manufacturing method for dried earthworm powder
08/08/2012EP2484361A1 Agent for reducing visceral fat weight
08/08/2012EP2483271A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
08/08/2012EP2483255A1 Oxazine derivatives and their use in the treatment of neurological disorders
08/08/2012EP2483233A2 Heteroatom containing substituted fatty acids
08/08/2012EP2482840A2 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
08/08/2012EP2482839A1 Means and methods for treating ischemic conditions
08/08/2012EP2482817A1 Methods of treating aneurysmal dilatation, blood vessel wall weakness and specifically abdominal aortic and thoracic aneurysm using matrix metalloprotease-2 inhibitors
08/08/2012EP2482658A1 Methods and compositions for treatment of raynaud's phenomenon
08/08/2012EP2205253B1 Composition and method inhibiting inflammation
08/08/2012EP2200622B1 Adherent cells from adipose or placenta tissues and use thereof in therapy
08/08/2012EP2152753B1 Antibodies against ramp3
08/08/2012EP2066680B1 Triphenylphosphonium thionitrite nitric oxide donors
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 1595